TOTAL COMPLEMENT ACTIVITY INCREASED

TOTAL COMPLEMENT ACTIVITY INCREASED was reported 53 times

TOTAL COMPLEMENT ACTIVITY INCREASED is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 CD19-directed Cytolytic Antibody [EPC] 1 0.0012
1 Complement Inhibitor [EPC] 42 0.0007
2 Selective T Cell Costimulation Blocker [EPC] 1 0.0002
3 Provitamin D2 Compound [EPC] 3 0.0001
4 Vitamin D3 Analog [EPC] 1 0.0000
5 Alkaloid [EPC] 1 0.0000
6 Leukotriene Receptor Antagonist [EPC] 1 0.0000
7 Tetracycline-class Drug [EPC] 1 0.0000
8 Azole Antifungal [EPC] 2 0.0000
9 Nitrate Vasodilator [EPC] 1 0.0000
10 Dietary Cholesterol Absorption Inhibitor [EPC] 1 0.0000
11 Programmed Death Receptor-1 Blocking Antibody [EPC] 1 0.0000
12 Dihydropyridine Calcium Channel Blocker [EPC] 3 0.0000
13 Calcineurin Inhibitor Immunosuppressant [EPC] 1 0.0000
14 Histamine-2 Receptor Antagonist [EPC] 1 0.0000
15 Leukocyte Growth Factor [EPC] 1 0.0000
16 Calcium [EPC] 1 0.0000
17 Phosphodiesterase 4 Inhibitor [EPC] 1 0.0000
18 Loop Diuretic [EPC] 2 0.0000
19 Alkylating Drug [EPC] 1 0.0000
20 Opioid Agonist [EPC] 1 0.0000
21 Platinum-based Drug [EPC] 1 0.0000
22 Vitamin D [EPC] 1 0.0000
23 CD20-directed Cytolytic Antibody [EPC] 1 0.0000
24 Corticosteroid [EPC] 4 0.0000
25 Vitamin B12 [EPC] 1 0.0000
26 HMG-CoA Reductase Inhibitor [EPC] 1 0.0000
27 Vitamin C [EPC] 1 0.0000
28 Kinase Inhibitor [EPC] 1 0.0000
29 Platelet Aggregation Inhibitor [EPC] 1 0.0000
30 Proton Pump Inhibitor [EPC] 1 0.0000
31 Nonsteroidal Anti-inflammatory Drug [EPC] 2 0.0000
32 Benzodiazepine [EPC] 1 0.0000
33 Tumor Necrosis Factor Blocker [EPC] 1 0.0000